chr1-32780201-C-G
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_003680.4(YARS1):āc.1218G>Cā(p.Leu406=) variant causes a synonymous change. The variant allele was found at a frequency of 0.098 in 1,614,056 control chromosomes in the GnomAD database, including 8,652 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L406L) has been classified as Likely benign.
Frequency
Consequence
NM_003680.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
YARS1 | NM_003680.4 | c.1218G>C | p.Leu406= | synonymous_variant | 11/13 | ENST00000373477.9 | |
YARS1 | XM_011542347.3 | c.588G>C | p.Leu196= | synonymous_variant | 9/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
YARS1 | ENST00000373477.9 | c.1218G>C | p.Leu406= | synonymous_variant | 11/13 | 1 | NM_003680.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.104 AC: 15744AN: 152072Hom.: 905 Cov.: 31
GnomAD3 exomes AF: 0.104 AC: 26054AN: 251392Hom.: 1860 AF XY: 0.0968 AC XY: 13150AN XY: 135856
GnomAD4 exome AF: 0.0974 AC: 142393AN: 1461866Hom.: 7745 Cov.: 32 AF XY: 0.0959 AC XY: 69737AN XY: 727232
GnomAD4 genome AF: 0.104 AC: 15760AN: 152190Hom.: 907 Cov.: 31 AF XY: 0.106 AC XY: 7863AN XY: 74438
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 04, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 23, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Charcot-Marie-Tooth disease dominant intermediate C Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at